Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1968 Oct;34(2):267–276. doi: 10.1111/j.1476-5381.1968.tb07050.x

The formation and release of metaraminol during exposure to warm or cold environments

G E Johnson, T A Pugsley
PMCID: PMC1703345  PMID: 5687587

Abstract

1. Rats were injected intraperitoneally with alpha-methyl-m-tyrosine (400 mg/kg) and placed at either 27° C or 4° C. The levels of alpha-methyl-m-tyramine, metaraminol and noradrenaline were determined in heart tissue after 1, 4 and 12 hr of treatment. The excretion of metaraminol, alpha-methyl-m-tyramine, noradrenaline, adrenaline and 3-methoxy-4-hydroxyphenylglycol (MHPG) was also estimated in both treated and control rats.

2. Cold exposure increased both the formation and excretion of metaraminol. Hearts removed from the cold-stressed rats 4 hr after injection contained significantly more metaraminol than hearts taken from animals maintained in the warm environment. Twelve hours after treatment, no metaraminol remained in the hearts of cold-exposed rats, whereas significant quantities of the amine still remained in the hearts of rats kept at 27° C. These results support the false transmitter concept advanced for metaraminol as they demonstrate that in vivo sympathetic stimulation can increase both the formation and release of metaraminol.

3. Alpha-methyl-m-tyrosine produced a greater fall in cardiac noradrenaline in the rats kept at 27° C. Whereas an approximate mole-for-mole replacement of metaraminol for noradrenaline existed at 27° C, no such relationships existed at 4° C. Twelve hours after treatment the hearts of cold-stressed rats contained no metaraminol and only 40% of control noradrenaline levels. These results do not support the necessity for a mole-for-mole replacement of noradrenaline with metaraminol to produce a catecholamine loss.

4. Alpha-methyl-m-tyrosine depressed the noradrenaline excretion for at least 24 hr in the cold-stressed rats. Excretion of 3-methoxy-4-hydroxyphenylglycol was also lower in the treated rats between 0 and 12 hr in the cold but rose abruptly between 12 and 24 hr to exceed the quantity excreted by the control animals. This increase suggests an increase in noradrenaline synthesis, which may be related to the depletion of metaraminol from the body.

5. The results of this paper support the postulate that metaraminol may function as a false transmitter. They do not agree with the concept that the loss of noradrenaline from tissue sites is dependent upon a mole-for-mole replacement with metaraminol.

Full text

PDF
267

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CARLSSON A., LINDQVIST M. In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine. Acta Physiol Scand. 1962 Jan;54:87–94. doi: 10.1111/j.1748-1716.1962.tb02331.x. [DOI] [PubMed] [Google Scholar]
  2. CROUT J. R., ALPERS H. S., TATUM E. L., SHORE P. A. RELEASE OF METARAMINOL (ARAMINE) FROM THE HEART BY SYMPATHETIC NERVE STIMULATION. Science. 1964 Aug 21;145(3634):828–829. doi: 10.1126/science.145.3634.828. [DOI] [PubMed] [Google Scholar]
  3. Gutman Y., Weil-Malherbe H. Subcellular distribution of noradrenaline after cold exposure. Br J Pharmacol Chemother. 1967 May;30(1):4–10. doi: 10.1111/j.1476-5381.1967.tb02107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Johnson G. E., Mickle D. The influence of cold exposure on the in vivo release of metaraminol. Br J Pharmacol Chemother. 1966 Nov;28(2):246–254. doi: 10.1111/j.1476-5381.1966.tb01891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Johnson G. E., Pritzker K. The influence of the dopa decarboxylase inhibitor Ro4-4602 on the urinary excretion of catecholamines in cold-stressed rats. J Pharmacol Exp Ther. 1966 Jun;152(3):432–438. [PubMed] [Google Scholar]
  6. KOPIN I. J., HERTTING G., GORDON E. K. Fate of norepinephrine-H3 in the isolated perfused rat heart. J Pharmacol Exp Ther. 1962 Oct;138:34–40. [PubMed] [Google Scholar]
  7. Maickel R. P., Matussek N., Stern D. N., Brodie B. B. The sympathetic nervous system as a homeostatic mechanism. I. Absolute need for sympathetic nervous function in body temperature maintenance of cold-exposed rats. J Pharmacol Exp Ther. 1967 Jul;157(1):103–110. [PubMed] [Google Scholar]
  8. Oliverio A., Stjärne L. Acceleration of noradrenaline turnover in the mouse heart by cold exposure. Life Sci. 1965 Dec;4(23):2339–2343. doi: 10.1016/0024-3205(65)90258-4. [DOI] [PubMed] [Google Scholar]
  9. Porter C. C., Torchiana M. L., Totaro J. A., Stone C. A. Displacement of norepinephrine from the rat heart by 14C-metaraminol. Biochem Pharmacol. 1967 Nov;16(11):2117–2124. doi: 10.1016/0006-2952(67)90009-3. [DOI] [PubMed] [Google Scholar]
  10. Pugsley T. A., Johnson G. E. Modified method for the estimation of metaraminol and alpha-methyl-m-tyramine. J Pharm Pharmacol. 1968 Jun;20(6):490–491. doi: 10.1111/j.2042-7158.1968.tb09794.x. [DOI] [PubMed] [Google Scholar]
  11. SHORE P. A., BUSFIELD D., ALPERS H. S. BINDING AND RELEASE OF METARAMINOL: MECHANISM OF NOREPINEPHRINE DEPLETION BY ALPHA-METHYL-M-TYROSINE AND RELATED AGENTS. J Pharmacol Exp Ther. 1964 Nov;146:194–199. [PubMed] [Google Scholar]
  12. Spector S., Gordon R., Sjoerdsma A., Udenfriend S. End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis. Mol Pharmacol. 1967 Nov;3(6):549–555. [PubMed] [Google Scholar]
  13. UDENFRIEND S., ZALTZMAN-NIRENBERG P. ON THE MECHANISM OF NOREPINEPHRINE DEPLETION BY ARAMINE. Life Sci. 1964 Jul;3:695–702. doi: 10.1016/0024-3205(64)90020-7. [DOI] [PubMed] [Google Scholar]
  14. von EULER U., LISHAJKO F. Improved technique for the fluorimetric estimation of catecholamines. Acta Physiol Scand. 1961 Apr;51:348–355. doi: 10.1111/j.1748-1716.1961.tb02128.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES